• Blog

    post #024
    February 22, 2023

    Metal Chemistry of Alzheimer’s Disease The metal ion hypothesis proposed that AD was associated with dyshomeostasis of metal ions, most particularly…

    post #023
    February 15, 2023

    Alzheimers…!Was a problem, is a problem, …, would not be a PROBLEM.Another antibody lecanemab-irmb (by Eisai and Biogen), following donanemab…

    post #022
    January 26, 2023

    Machine learning and AI based methods are rapidly shaping the future technologies. Computer aided drug design is no exception. This…

    post #021
    January 19, 2023

    Rigorous absolute binding free energy (ABFE) calculations are increasingly gaining attention as an important component of modern virtual screening (VS)…

    post #020
    January 18, 2023

    Pan-assay interference compounds, or PAINS, are a specific group of compounds with defined structures that fall into several classes. However,…

    post #019
    January 17, 2023

    The FDA approved the cMet/ALK dual inhibitor Crizotinib in 2011. In human cancers, the overexpression of the c-Met protein has…

    post #018
    January 11, 2023

    In the field of drug discovery, ML can be used to analyze large amounts of data from various sources, including…

    Load More

    End of Content.